FDA-Approved Mydriasis Reversal with RYZUMVI™
RYZUMVI™ (Phentolamine Ophthalmic Solution) 0.75% is the first and only FDA-approved eye drop for reversing pharmacologically-induced pupil dilation caused by adrenergic agonists or parasympatholytic agents. With just 1-2 drops, RYZUMVI™ works to constrict pupils quickly and efficiently, typically reversing dilation within 90 minutes. Each pack contains six pouches, each with five single-use vials, ensuring safe and sterile application. Proper refrigeration between 2°C and 8°C is required to maintain product integrity.
This innovative solution provides reliable results, offering optometrists and ophthalmologists a trusted tool for managing patient care post-dilation.